Curaleaf Holdings Inc. (CURLF)

[FUNMAN]

Curaleaf - nice story - GMP Securities Stock Picks, October 2019


With that positive note in mind, here are GMP’s Best Ideas in tech and healthcare.


https://www.cantechletter.com/2019/10/october-2019-these-are-gmps-top-tech-and-healthcare-stock-picks/


Curaleaf Holdings (CSE:CURA)



US cannabis company Curaleaf Holdings (Curaleaf Holdings Stock Quote, Chart, News CSE:CURA) continues to be one of analyst Robert Fagan’s Best Ideas for the year. Along with its currently attractive valuation (Curaleaf is trading at at an “unfair” discount to its peers, Fagan says), industry-leading platform and accretive merger with Select as of May of this year, CURA released its second quarter 2019 earnings in late August, which saw the company flip to profitability for the first time.



That marked a milestone for the company, says Fagan.



“The positive EBITDA achievement was mainly driven by operating leverage, which we expect to continue with no major expense base additions required to handle future volume increases. In our view, this suggests CURA’s platform has reached an inflection point for OPEX, setting the stage for future margin growth,” Fagan writes.



The analyst rates CURA a “Buy” with a target price of $24.00, representing a projected return of 234.7 per cent at the time of publication.